Literature DB >> 29314242

Comorbidities Only Account for a Small Proportion of Excess Mortality After Fracture: A Record Linkage Study of Individual Fracture Types.

Weiwen Chen1, Judy M Simpson2, Lyn M March3,4,5, Fiona M Blyth3,6, Dana Bliuc1, Thach Tran1, Tuan V Nguyen1,7,8, John A Eisman1,9,10, Jacqueline R Center1,9,11.   

Abstract

Nonhip, nonvertebral (NHNV) fractures constitute the majority of osteoporotic fractures, but few studies have examined the association between these fractures, comorbidity, and mortality. Our objective was to examine the relationship between individual nonhip, nonvertebral fractures, comorbidities, and mortality. The prospective population-based cohort of 267,043 subjects (45 and Up Study, Australia) had baseline questionnaires linked to hospital administrative and all-cause mortality data from 2006 to 2013. Associations between fracture and mortality were examined using multivariate, time-dependent Cox models, adjusted for age, prior fracture, body mass index, smoking, and comorbidities (cardiovascular disease, diabetes, stroke, thrombosis, and cancer), and survival function curves. Population attributable fraction was calculated for each level of risk exposure. During 1,490,651 person-years, women and men experienced 7571 and 4571 fractures and 7064 deaths and 11,078 deaths, respectively. In addition to hip and vertebral fractures, pelvis, humerus, clavicle, rib, proximal tibia/fibula, elbow and distal forearm fractures in both sexes, and ankle fractures in men were associated with increased multivariable-adjusted mortality hazard ratios ranging from 1.3 to 3.4. Comorbidity independently added to mortality such that a woman with a humeral fracture and 1 comorbidity had a similarly reduced 5-year survival as that of a woman with a hip fracture and no comorbidities. Population mortality attributable to any fracture without comorbidity was 9.2% in women and 5.3% in men. All proximal nonhip, nonvertebral fractures in women and men were associated with increased mortality risk. Coexistent comorbidities independently further increased mortality. Population attributable risk for mortality for fractures was similar to cardiovascular disease and diabetes, highlighting their importance and potential benefit for early intervention and treatment.
© 2018 American Society for Bone and Mineral Research. © 2018 American Society for Bone and Mineral Research.

Entities:  

Keywords:  AGING; EPIDEMIOLOGY; PRACTICE/POLICY-RELATED ISSUES

Mesh:

Year:  2018        PMID: 29314242     DOI: 10.1002/jbmr.3374

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  12 in total

Review 1.  Bone health in ageing men.

Authors:  Karel David; Nick Narinx; Leen Antonio; Pieter Evenepoel; Frank Claessens; Brigitte Decallonne; Dirk Vanderschueren
Journal:  Rev Endocr Metab Disord       Date:  2022-07-16       Impact factor: 9.306

2.  Impact of osteoporotic fracture type and subsequent fracture on mortality: the Tromsø Study.

Authors:  D Alarkawi; D Bliuc; T Tran; L A Ahmed; N Emaus; A Bjørnerem; L Jørgensen; T Christoffersen; J A Eisman; J R Center
Journal:  Osteoporos Int       Date:  2019-10-26       Impact factor: 4.507

3.  Risk factors for imminent fractures: a substudy of the FRISBEE cohort.

Authors:  L Iconaru; M Moreau; F Baleanu; V Kinnard; A Charles; A Mugisha; M Surquin; F Benoit; R Karmali; M Paesmans; J J Body; P Bergmann
Journal:  Osteoporos Int       Date:  2021-01-07       Impact factor: 4.507

4.  Fragility Fractures in Postmenopausal Women: Development of 5-Year Prediction Models Using the FRISBEE Study.

Authors:  Felicia Baleanu; Michel Moreau; Alexia Charles; Laura Iconaru; Rafik Karmali; Murielle Surquin; Florence Benoit; Aude Mugisha; Marianne Paesmans; Michel Rubinstein; Serge Rozenberg; Pierre Bergmann; Jean-Jacques Body
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

5.  Does the Prediction Accuracy of Osteoporotic Fractures by BMD and Clinical Risk Factors Vary With Fracture Site?

Authors:  L Iconaru; M Moreau; V Kinnard; F Baleanu; M Paesmans; R Karmali; J J Body; P Bergmann
Journal:  JBMR Plus       Date:  2019-10-29

6.  Osteoporosis treatment gap in a prospective cohort of volunteer women.

Authors:  L Iconaru; C Smeys; F Baleanu; V Kinnard; M Moreau; S Cappelle; M Surquin; M Rubinstein; S Rozenberg; M Paesmans; R Karmali; P Bergmann; J J Body
Journal:  Osteoporos Int       Date:  2020-03-03       Impact factor: 4.507

7.  Recovery of quality of life is associated with lower mortality 5-year post-fracture: the Australian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (AusICUROS).

Authors:  Jason Talevski; Kerrie M Sanders; Sara Vogrin; Gustavo Duque; Alison Beauchamp; Ego Seeman; Sandra Iuliano; Axel Svedbom; Fredrik Borgström; John A Kanis; Amanda L Stuart; Sharon L Brennan-Olsen
Journal:  Arch Osteoporos       Date:  2021-07-15       Impact factor: 2.617

8.  Refracture and mortality following hospitalization for severe osteoporotic fractures: The Fractos Study.

Authors:  Christian Roux; Thierry Thomas; Julien Paccou; Geoffray Bizouard; Anne Crochard; Emese Toth; Magali Lemaitre; Frédérique Maurel; Laure Perrin; Florence Tubach
Journal:  JBMR Plus       Date:  2021-05-14

Review 9.  Promoting mobility and healthy aging in men: a narrative review.

Authors:  P R Ebeling; F Cicuttini; D Scott; G Jones
Journal:  Osteoporos Int       Date:  2019-07-19       Impact factor: 4.507

10.  Cost-effectiveness of secondary fracture prevention intervention for Medicare beneficiaries.

Authors:  Smita Nayak; Andrea Singer; Susan L Greenspan
Journal:  J Am Geriatr Soc       Date:  2021-08-03       Impact factor: 7.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.